ARTICLE | Clinical News
Albuferon: Began Phase I trial
March 26, 2001 8:00 AM UTC
Human Genome Sciences Inc. (HGSI), Rockville, Md. Product: Albuferon Business: Infectious diseases Therapeutic category: Immune stimulation Target: Unknown Description: Fusion protein of interferon a...